GSK

Forecast & Rating8 analysts currently cover GSK, with about 37.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $59.33, about 17.0% upside from the current price of $50.70. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 52.7% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on GSK's outlook. Data as of Sep 15, 2026; for reference only and not investment advice.